In the Press COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors June 2024 Read More COUR Pharmaceuticals Appoints Paul M. Peloso, MD, as Chief Medical Officer May 2024 Read More COUR Pharmaceuticals Secures $105 Million in Series A Financing Co-Led by Lumira Ventures and Alpha Wave Ventures January 2024 Read More COUR Pharmaceuticals Appoints Dannielle Appelhans as Chief Operating Officer July 2023 Read More
COUR Pharmaceuticals Secures $105 Million in Series A Financing Co-Led by Lumira Ventures and Alpha Wave Ventures January 2024 Read More